Intravenous Immunoglobulins Are Attracting New Investors; Product Holds Massive Potential in the Healthcare Space

Intravenous Immunoglobulin Have Abilities to Treat Severe Immunodeficiency Patients; Product to Witness High Demand in the Coming Years

Fortune Business Insights predicts the Global Intravenous Immunoglobulin Market to reach a value of US$ 15,789.1 Mn from US$ 9,787.6 Mn. The forecast period is set from 2018 and the market is expected to grow at a CAGR of 6.2%. All information related to the market is provided in the report, titled, “Intravenous Immunoglobulin Market Size, Share and Global Trend by Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025”.  The rising incidence of immunodeficiency diseases in both emerging and developed nations is propelling growth of the Intravenous Immunoglobulin market.

Browse Complete Report [email protected]

Increasing Adoption of Immunoglobulins to Help Asia Pacific Register Fastest Growth

According to the report, The Global Intravenous Immunoglobulin Market was dominated by North America with a market value of US$ 5,587.4 Mn in 2017. The region is likley to remain dominant through the forecast period as well due to the presence of first line treatment for critical immune disorders. Other factors boosting the market in the region are rising number of patients and efficient results of the intravenous immunoglobulin treatment.

On the other side, the market in Asia Pacific is anticipated to grpow at faster rate in the coming years on account of the rise in awareness about the treatment option avaiulable for immunologic deficiencies. In addition to this, the rise in adoption and expenditure of immunoglobulins in economies such as Japan, China,and Indiais anticipated to boost the market in the region.

Key Segmentation:

By Indication

  • Primary Immunodeficiency
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Guillain-Barré Syndrome (GBS)
  • Immune Thrombocytopenic Purpura (ITP)
  • Multifocal Motor Neuropathy (MMN)
  • Others

By Form

  • Liquid
  • Lyophilized

By End User

  • Hospitals
  • Clinics
  • Homecare

By Geography

  • North America (the U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America
  • Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Get PDF Brochure of this [email protected]

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Intravenous Immunoglobulin market. Some of the companies operating the global Intravenous Immunoglobulin market are;

  • CSL Behring
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • LFB SA and Shanghai RAAS Blood Products Co., Ltd.

Grifols, S.A., Leading Market with Better Product Offerings

Analysts at Fortune Business Insights foresees the Grifols, S.A., to emerge as the dominant player in the global market for intravenous immunoglobulin market. This is because this company was leading the market in the year 2017 as well, all because oftheir product offerings and the usual route of administration, whioch ultimately dominated a considerate proportion of share ion the market. Besides this, Grifols, S.A., accounts for largest revenues from well developed regions namely Europe and North America.

More Trending Topics From Fortune Business [email protected] 

Global Companion Animal Healthcare Market to Witness Remarkable Growth on Account of Improved Availability of Animal Healthcare Accessories

Medical Radiation Shielding Market 2019 Global Analysis, Opportunities and Forecast To 2026

Hematology Analyzers and Reagents Market: 2019 Potential Growth, Size, Share, Regional Analysis, Industry Outlook, Competitive Landscape, Trends

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *